BioSpace News Archive

Sunshine Biopharma, Inc. today closed its previously announced private placement pursuant to a securities purchase agreement entered into on March 10, 2022 with certain institutional and accredited investors.

Albany NY, United States: A fresh market intelligence study by Transparency Market Research points out the global CT scanners market features a moderately consolidated vendor landscape.

Albany NY, United States: The world market for surgical tables is dominated by already established international market vendors whilst local market participants jostle to make a positive impact on the said industry.

Physical therapy services has helped a lot in promoting health and wellness, these are specially designed exercises to help patient gain physical abilities.

Albany NY, United States: The global microbiome sequencing services market has a highly fragmented vendor landscape, says Transparency Market Research, in a recently published report.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Oppenheimer 32nd Annual Healthcare Conference.

Nutcracker Therapeutics, Inc., a biotech company developing RNA therapeutics using its proprietary biochip-based manufacturing platform, today announced it has raised $167 million in Series C financing led by ARCH Venture Partners.

CAMP4 Therapeutics today announced that it has appointed Ann Barbier, M.D., Ph.D., as Chief Medical Officer, responsible for leading all clinical research and development, medical affairs and related functions.

Masimo announced a major expansion of Masimo Patient SafetyNet™, its premier hospital remote patient monitoring and clinician notification platform, with the addition of secure telehealth capabilities – making an already powerful solution even more versatile and comprehensive.

Elektrofi & IPA announced they are entering into a collaboration to explore a high-concentration formulation of IPA’s COVID-19 antibody cocktail, PolyTope® TATX-03.